Status: current, Primitive. Date: 31-Dec 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3159701000168112 | tildrakizumab (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3159711000168110 | tildrakizumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tildrakizumab | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tildrakizumab | has intended active ingredient | True | tildrakizumab | Inferred relationship | Some | 1 |
| tildrakizumab 100 mg/mL injection, syringe | has Australian BoSS | True | tildrakizumab | Inferred relationship | Some | 353580678 |
| tildrakizumab 100 mg/mL injection, syringe | has intended active ingredient | True | tildrakizumab | Inferred relationship | Some | 353580678 |
| Ilumya 100 mg/mL injection, syringe | has intended active ingredient | True | tildrakizumab | Inferred relationship | Some | 2061946554 |
| Ilumya 100 mg/mL injection, syringe | has Australian BoSS | True | tildrakizumab | Inferred relationship | Some | 2061946554 |
This concept is not in any reference sets
FHIR